These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 32388331)

  • 21. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
    Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
    Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
    [No Abstract]   [Full Text] [Related]  

  • 22. The diabetic lung: An easy target for SARS-CoV-2?
    Caruso I; Giorgino F
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3346. PubMed ID: 32426928
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.
    Sinha S; Sehgal A; Sehgal R
    Drug Discov Ther; 2020; 14(4):161-170. PubMed ID: 32908071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis.
    Parveen R; Sehar N; Bajpai R; Agarwal NB
    Diabetes Res Clin Pract; 2020 Aug; 166():108295. PubMed ID: 32623032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).
    Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(3):251-254. PubMed ID: 32247213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
    Li Y; Han X; Alwalid O; Cui Y; Cao Y; Liu J; Gu J; Wang L; Fan Y; Shi H
    Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review.
    Singh AK; Khunti K
    Diabetes Res Clin Pract; 2020 Jul; 165():108266. PubMed ID: 32533989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID 19 could trigger global diabetes burden - A hypothesis.
    Mukherjee S; Banerjee O; Singh S; Maji BK
    Diabetes Metab Syndr; 2020; 14(5):963-964. PubMed ID: 32604015
    [No Abstract]   [Full Text] [Related]  

  • 29. An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms.
    Hayden MR
    Cells; 2020 Nov; 9(11):. PubMed ID: 33202960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review.
    Zaki N; Alashwal H; Ibrahim S
    Diabetes Metab Syndr; 2020; 14(5):1133-1142. PubMed ID: 32663789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
    Jagat J M; Kalyan K G; Subir R
    Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and treatment of COVID-19 patients in northeast Chongqing.
    Wan S; Xiang Y; Fang W; Zheng Y; Li B; Hu Y; Lang C; Huang D; Sun Q; Xiong Y; Huang X; Lv J; Luo Y; Shen L; Yang H; Huang G; Yang R
    J Med Virol; 2020 Jul; 92(7):797-806. PubMed ID: 32198776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes and COVID-19 : Disease-Management-People.
    Peric S; Stulnig TM
    Wien Klin Wochenschr; 2020 Jul; 132(13-14):356-361. PubMed ID: 32435867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes.
    Fernández E; Cortazar A; Bellido V
    Diabetes Res Clin Pract; 2020 Aug; 166():108348. PubMed ID: 32711000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
    Wang Y; Foo R; Thum T
    J Mol Cell Cardiol; 2020 Sep; 146():41-42. PubMed ID: 32687852
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
    Brufsky A
    J Med Virol; 2020 Jul; 92(7):770-775. PubMed ID: 32293710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery.
    Lores E; Wysocki J; Batlle D
    Clin Sci (Lond); 2020 Nov; 134(21):2791-2805. PubMed ID: 33135725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic.
    Ghosh A; Dutta K; Tyagi K; Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):577-578. PubMed ID: 32416526
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes care during COVID-19 lockdown at a tertiary care centre in India.
    Joshi R; Atal S; Fatima Z; Balakrishnan S; Sharma S; Joshi A
    Diabetes Res Clin Pract; 2020 Aug; 166():108316. PubMed ID: 32673697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.